fda stops tirzepatide says the weight-loss drug shortage is over The FDA says the Zepbound

2026 Rules VA and TRICARE GLP-1 coverage in 2026: who qualifies for Wegovy or Zepbound, CHAMPVA rules, whether active duty can take GLP-1s, and what to do if denied

However, there may be links between hair loss and type 2 diabetes

The research was presented at the American Heart Association Scientific Sessions 2025 in New Orleans

The Living Health Integrative Medicine Philosophy We dont believe in shortcuts that sacrifice long-term health

Clinical research indicates tanning activity from low, intermittent doses via injection

Seek medical advice if experiencing your first suspected infection, if pregnant or breastfeeding, if symptoms persist beyond seven days despite treatment, or if you have recurrent infections (four or more episodes within twelve months)